Dual CDK4/6-PI3K/mTOR inhibition reinforces cytostatic programs and tumor control in preclinical models of primary and metastatic osteosarcoma
双重 CDK4/6-PI3K/mTOR 抑制可增强原发性和转移性骨肉瘤临床前模型中的细胞抑制程序和肿瘤控制。
期刊:Neoplasia
影响因子:7.7
doi:10.1016/j.neo.2025.101266
Barghi, Farinaz; Saadatzadeh, M Reza; Dobrota, Erika A; Shannon, Harlan E; Bailey, Barbara J; Young, Courtney; Malko, Rada; Justice, Ryli; Riyahi, Niknam; Davis, Christopher; Bijangi-Vishehsaraei, Khadijeh; Kreklau, Keiko; Stevens, Lauren K; Koenig, Jenna; Sulayman, Shirzat; Liu, Sheng; Wan, Jun; Trowbridge, Melissa A; Coy, Kathy; Kennedy, Felicia M; Sinn, Anthony L; Just, Marissa; Jackson, Kyle W; Sandusky, George; Wurtz, L Daniel; Collier, Christopher D; Mitchell, Dana; Seiden, Emily E; Greenfield, Edward M; Doud, Emma; Mosley, Amber; Angus, Steven P; Ferguson, Michael J; Pandya, Pankita H; Pollok, Karen E
